Impact of the Angiotensin-Converting Enzyme (ACE) Inhibitors on the Course of the Acute Respiratory Distress Syndrome (ARDS) Developed During COVID-19 and Other Severe Respiratory Infections Under Hyperferritinemia Conditions: A Cohort Study

Background Angiotensin-converting enzyme 2 (ACE2) is not only the entry route of SARS-CoV-2 infection but also triggers a major mechanism of COVID-19 aggravation by promoting a hyperinflammatory state, leading to lung injury, hematological and immunological dysregulation. The impact of ACE2 inhibito...

Full description

Bibliographic Details
Main Authors: Magda Rurua, Elena Pachkoria, Tamar Sanikidze, K Machvariani, George Ormocadze, Tinatin Jomidava, Diana Dzidziguri, Levan Ratiani
Format: Article
Language:English
Published: SAGE Publishing 2023-06-01
Series:Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Online Access:https://doi.org/10.1177/11795484231180391